US2022183296A1PendingUtilityA1
Herbicidal composition and method for controlling weeds
Est. expiryMar 20, 2039(~12.6 yrs left)· nominal 20-yr term from priority
Inventors:Yoshinao Sada
A01N 43/54A01N 25/32A01N 43/84A01N 43/82A01N 57/20A01N 43/38
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided is a herbicidal composition comprising a PPO inhibitor and glufosinate or its salt, wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is 1/2,000 or less. The herbicidal composition can effectively control weeds with reduced crop injury.
Claims
exact text as granted — not AI-modified1 . A herbicidal composition comprising a PPO inhibitor and glufosinate or its salt, wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is 1/2,000 or less.
2 . The herbicidal composition according to claim 1 , wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is from 1/2,000,000 to 1/2,000.
3 . The herbicidal composition according to claim 1 , wherein the PPO inhibitor is selected from the group consisting of saflufenacil, trifludimoxazin, flumioxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate, sulfentrazone, lactofen, fomesafen or its salt, flumiclorac-pentyl, carfentrazone-ethyl, fluthiacet-methyl, and tiafenacil.
4 . A method for controlling weeds in a crop field comprising a step of applying a PPO inhibitor and glufosinate or its salt to the weeds or a soil of the place where the weeds are growing or will grow, wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is 1/2,000 or less.
5 . The method according to claim 4 , wherein the weight ratio of the PPO inhibitor to glufosinate or its salt is from 1/2,000,000 to 1/2,000.
6 . The method according to claim 4 , wherein the PPO inhibitor is selected from the group consisting of saflufenacil, trifludimoxazin, flumioxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate, sulfentrazone, lactofen, fomesafen or its salt, flumiclorac-pentyl, carfentrazone-ethyl, fluthiacet-methyl, and tiafenacil.Join the waitlist — get patent alerts
Track US2022183296A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.